Summary

Overview
Global pharmaceutical visual inspection systems market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Pharmaceutical visual inspection aims to determine the absence or presence of visible particles within products. An inspection machine is mostly helpful to the pharmaceutical sector. It has numerous other applications in the nutraceutical and nutritional supplement industries. It works well as a capsule sorting device that removes flawed capsules. Typically, this kind of gadget uses little electricity and requires little upkeep.
Especially during formulation development, where visual inspection is mainly used to detect proteinaceous particles, a ranking of the extent of visible particle formation can be beneficial to differentiate between formulations with only a few visible particles and those with a high number of visible particles. During formulation development, a visual inspection is performed to judge if particles are formed within formulations. For this application, usually a small number of vials/containers is inspected and a rating of the extent of visible particle formation can be helpful to differentiate between formulations.
Market Dynamics: Drivers
Increasing demand for advanced machines
The increasing demand for advanced visual inspection machines is expected to drive the market over the forecast period. Technical development is an ongoing process and machine vision inspection systems are not a novelty but a necessity. Constantly changing factory automation and the need to adhere to newer standards of quality parameters make it necessary for manufacturers to use advanced machine vision in their production processes.
For instance, on July 25, 2023, Norwalt launched its new bottle vision inspection system, the Vue Inspection System. Designed in the company’s Vision Systems Lab, the new product aims to integrate standardized vision components with custom-made elements and deep learning tools. Norwalt conceptualized, designed and engineered the Vue Inspection System in its Vision Systems Lab.
The facility incorporates visual inspection and deep learning tools, including artificial intelligence (AI) vision innovations and 3D profiling. The custom automation and line integration machinery manufacturer also integrates optical character recognition (OCR) and verification via optical character verification (OCV) at its lab.
Advanced visual inspection systems use cutting-edge technologies such as high-resolution cameras, machine learning algorithms and computer vision to detect even minute defects in pharmaceutical products. This level of precision is challenging to achieve through manual inspection and contributes to a higher level of product quality.
For instance, on October 12, 2022, the Antares Vision Group launched a new automatic visual inspection system that guarantees 100% quality inspections of pre-filled (PFS) syringes. The VRI-VI 060 S series detects particles, cosmetics and filling level defects.
Further, the increasing adoption of various types of visual inspection machines for various pharmaceutical applications, enhanced machine reputation, enhanced data quality, accurate results and enhanced productivity and increasing technological advancements are the factors expected to drive the market over the forecast period.
Restraints
Factors such as high cost associated with the visual inspection systems, lack of skilled professionals, complications associated with the visual inspection machines and these machines are only able to detect large flaws are expected to hamper the market.
Segment Analysis
The global pharmaceutical visual inspection systems market is segmented based on machine type, technology, application, end-user and region.
The automatic machines segment accounted for approximately 48.4% of the pharmaceutical visual inspection systems market share
The automatic visual inspection machines segment is expected to hold the largest market share over the forecast period. Automatic inspection systems using machine vision significantly reduce wastage thereby improving the ROI. Defects are caught early in the production cycle and do not penetrate through, significantly reducing wastage. Additionally, it prevents recalls or returns of defective products, which enhances customer satisfaction and reduces extra shipping costs.
Automatic visual inspection machines operate at high speeds, allowing for rapid inspection of a large number of products within a short timeframe. This is particularly beneficial in industries with high production volumes. These types of machines also use AI technology to yield high accuracy and better inspection and defect detection of the pharmaceutical products.
For instance, on February 23, 2021, Stevanato Group launched an AI platform that reportedly leverages the benefits of human-like decision-making in automatic visual inspection equipment. The platform is designed to allow pharma companies to overcome the traditional trade-off between detection rate and false rejection rate. The product reportedly yields up to 99.9% accuracy, both for particle inspection and cosmetic defects detection.
Automation ensures a high level of consistency in inspection processes. These machines are programmed to follow specific parameters precisely, reducing the likelihood of errors and variations that may occur with manual inspection. Automatic visual inspection machines are equipped with advanced imaging technologies, such as high-resolution cameras and precision sensors. This enables them to detect subtle and microscopic defects that may be challenging for human inspectors to identify.
For instance, on February 03, 2021, Syntegon Technology installed the first fully validated visual inspection system utilizing Artificial Intelligence (AI) in an automated inspection machine. The installation constitutes a major step in the company’s sustained effort to introduce AI to pharmaceutical visual inspection, thereby exploring largely uncharted territory in the industry.
Geographical Analysis
North America accounted for approximately 42.5% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing technological advancements. North America especially the United States is known for its strong presence of major players such as pharmaceutical companies and medical device companies that play a very crucial role visual inspection systems market. The strong presence of major players mainly focuses on technological advancements like Artificial Intelligence (AI) technology for more precise inspections.
For instance, on May 28, 2023, ACIC Pharmaceuticals Inc. launched a cutting-edge robotic visual inspection machine for Ready-To-Use (RTU) containers. This state-of-the-art system employs advanced camera technology and Artificial Intelligence (AI) to deliver precise inspections for particulate matter and cosmetic defects. The machine can inspect different types of containers – such as vials, syringes, and cartridges – with varying sizes and shapes, and has a speed range of 6 to 20 BpM.
Competitive Landscape
The major global players in the pharmaceutical visual inspection systems market include Daiichi Jitsugyo Asia Pte. Ltd., Stevanato Group, Syntegon Technology GmbH, Sensum d.o.o., Yenchen Machinery Co., Ltd., United Pharmatek USA, Key International, Inc., Meliscout GmbH, BREVETTI CEA S.P.A, and SaintyCo among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global pharmaceutical visual inspection systems market. The focus of pharmaceutical companies shifted toward the production of essential drugs and vaccines to address the immediate needs of the pandemic. This may have influenced investment decisions and priorities, potentially impacting the adoption of visual inspection systems for COVID-19-related pharmaceuticals like COVID-19 vaccines. For instance, the inspection machines from Syntegon are used in the production of the novel mRNA Covid-19 vaccines.
Market Segmentation
By Machine Type
• Automatic
• Semi-Automatic
• Manual
By Technology
• Headspace Gas Analysis (HGA)
• High Voltage Leak Detection (HVLD)
• Laser Refraction
• Others
By Application
• Tablets
• Capsules
• Softgels
• Syringes
• Ampoules
• Vials
• Others
By End-User
• Pharmaceutical Companies
• Medical Device Companies
• Biopharmaceutical Companies
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global pharmaceutical visual inspection systems market segmentation based on machine type, technology, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of pharmaceutical visual inspection systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pharmaceutical visual inspection systems market report would provide approximately 69 tables, 73 figures and 189 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Machine Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Advanced Visual Inspection Machines
4.1.2. Restraints
4.1.2.1. High Cost Associated with Visual Inspection Machines
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. PESTLE Analysis
5.6. Unmet Needs
5.7. AI Impact Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Machine Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
7.1.2. Market Attractiveness Index, By Machine Type
7.2. Automatic*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automatic
7.4. Manual
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Headspace Gas Analysis (HGA)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. High Voltage Leak Detection (HVLD)
8.4. Laser Refraction
8.5. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Tablets*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Capsules
9.4. Softgels
9.5. Syringes
9.6. Ampoules
9.7. Vials
9.8. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Pharmaceutical Companies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Medical Device Companies
10.4. Biopharmaceutical Companies
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Daiichi Jitsugyo Asia Pte. Ltd.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Stevanato Group
13.3. Syntegon Technology GmbH
13.4. Sensum d.o.o.
13.5. Yenchen Machinery Co., Ltd.
13.6. United Pharmatek USA
13.7. Key International, Inc.
13.8. Meliscout GmbH
13.9. BREVETTI CEA S.P.A
13.10. SaintyCo
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us